|
Volume 271, Number 35,
Issue of August 30, 1996
pp. 21422-21429
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Determination of the Amino Acid Residue Involved in
[3H] -Funaltrexamine Covalent Binding in the Cloned
Rat µ Opioid Receptor
(Received for publication, March 1, 1996, and in revised form, June 6, 1996)
Chongguang
Chen
,
Jinling
Yin
,
J. Kim de
Riel
,
Renee L.
DesJarlais
§
,
Luca F.
Raveglia
¶
,
Jinmin
Zhu
and
Lee-Yuan
Liu-Chen
From the Department of Pharmacology and Fels
Institute for Molecular Biology and Cancer Research, Temple
University School of Medicine, Philadelphia, Pennsylvania 19140, § Department of Physical and Structural Chemistry,
SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania
19406, and ¶ Department of Chemistry, SmithKline Beecham
S.P.A., Via Zambeletti 20021, Baranzate, Milan, Italy
We previously demonstrated that
[3H] -funaltrexamine ([3H] -FNA)
labeled the rat µ opioid receptor expressed in Chinese hamster ovary
cells with high specificity, and [3H] -FNA-labeled
receptors migrated as one broad band with a mass of 80 kDa. In this
study, we determined the region and then the amino acid residue of the µ receptor involved in the covalent binding of
[3H] -FNA. [3H] -FNA-labeled receptors
were solubilized and purified to ~10% purity by immunoaffinity
chromatography with antibodies against a C-terminal domain peptide. The
site of covalent bond formation was determined to be within
Ala206-Met243 by CNBr cleavage of partially
purified labeled µ receptors and determinations of sizes of labeled
receptor fragments. The amino acid residue of -FNA covalent
incorporation was then determined by site-directed mutagenesis studies
within this region. Mutation of Lys233 to Ala, Arg, His,
and Leu completely eliminated covalent binding of
[3H] -FNA, although these mutants bound -FNA with
high affinity. Mutations of other amino acid residues did not affect
covalent binding of [3H] -FNA. These results indicate
that [3H] -FNA binds covalently to Lys233.
Since [3H] -FNA is a rigid molecule, the information
will be very useful for molecular modeling of interaction between
morphinans and the µ receptor.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. J. Meilandt, E. Barea-Rodriguez, S. A. K. Harvey, and J. L. Martinez Jr
Role of Hippocampal CA3 {micro}-Opioid Receptors in Spatial Learning and Memory
J. Neurosci.,
March 24, 2004;
24(12):
2953 - 2962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pil and J. Tytgat
Serine 329 of the {micro}-Opioid Receptor Interacts Differently with Agonists
J. Pharmacol. Exp. Ther.,
March 1, 2003;
304(3):
924 - 930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chavkin, J. P. McLaughlin, and J. P. Celver
Regulation of Opioid Receptor Function by Chronic Agonist Exposure: Constitutive Activity and Desensitization
Mol. Pharmacol.,
July 1, 2001;
60(1):
20 - 25.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. L. Prather, L. Song, E. T. Piros, P. Y. Law, and T. G. Hales
delta -Opioid Receptors Are More Efficiently Coupled to Adenylyl Cyclase Than to L-Type Ca2+ Channels in Transfected Rat Pituitary Cells
J. Pharmacol. Exp. Ther.,
November 1, 2000;
295(2):
552 - 562.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P.-Y. Law, L. J. Erickson, R. El-Kouhen, L. Dicker, J. Solberg, W. Wang, E. Miller, A. L. Burd, and H. H. Loh
Receptor Density and Recycling Affect the Rate of Agonist-Induced Desensitization of {micro}-Opioid Receptor
Mol. Pharmacol.,
August 1, 2000;
58(2):
388 - 398.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. V. Carman, L. S. Barak, C. Chen, L.-Y. Liu-Chen, J. J. Onorato, S. P. Kennedy, M. G. Caron, and J. L. Benovic
Mutational Analysis of Gbeta gamma and Phospholipid Interaction with G Protein-coupled Receptor Kinase 2
J. Biol. Chem.,
March 31, 2000;
275(14):
10443 - 10452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. McLaughlin, K. P. Hill, Q. Jiang, A. Sebastian, S. Archer, and J. M. Bidlack
Nitrocinnamoyl and Chlorocinnamoyl Derivatives of Dihydrocodeinone: In Vivo and In Vitro Characterization of µ-Selective Agonist and Antagonist Activity
J. Pharmacol. Exp. Ther.,
April 1, 1999;
289(1):
304 - 311.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. E. Spivak, C. L. Beglan, B. K. Seidleck, L. D. Hirshbein, C. J. Blaschak, G. R. Uhl, and C. K. Surratt
Naloxone Activation of µ-Opioid Receptors Mutated at a Histidine Residue Lining the Opioid Binding Cavity
Mol. Pharmacol.,
December 1, 1997;
52(6):
983 - 992.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|